Pancreatic Cancer Research

ResearcherFirst People's Hospital of KunshanNo recent work listed

Shi-qing Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8419-8039; OpenAlex author ID A5018190086. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. Co-author DOI 10.1038/s41419-023-05684-5↗
  2. Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer. First author DOI 10.1038/s41419-021-04201-w↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Min‐Bin Chen · 2 shared papers, 2021–2023 · strength 0.35
  2. Xiaoren Zhu · 2 shared papers, 2021–2023 · strength 0.35
  3. Zhen-yu Ye · 1 shared paper, 2023 · strength 0.20
  4. Yifan Zhang · 1 shared paper, 2023 · strength 0.20
  5. Yuan-yuan Liu · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.